Stockholm3 Test: Improving Prostate Cancer Detection Accuracy
The Stockholm3 blood test identifies clinically significant prostate cancer more effectively than traditional Prostate-Specific Antigen (PSA) screening, according to a study published in the Annals of Internal Medicine. Researchers at Karolinska Institutet found the new test detected 90 percent of aggressive tumors compared to 74 percent for PSA, without increasing the rate of unnecessary follow-up … Read more